-
Tofacitnib Citrate
Navê API Delîl Specification DYA DMF EU DMF CEP Tofacitnib Citrate Rheumatoid arthritis In-House -
Sugammadex Sodium
Navê API Delîl Specification DYA DMF EU DMF CEP Sugammadex Sodium Astengkirina neuromuscular In-House -
Sacubitril Hemicalcium
Navê API Delîl Specification DYA DMF EU DMF CEP Sacubitril Hemicalcium In-House -
Sofosbuvir
Navê API Delîl Specification DYA DMF EU DMF CEP Sofosbuvir HCV In-House 32048 √ -
Ribociclib 1374639-75-4
Navê API Delîl Innovator Dîroka Dawîbûna Patentê (DYA) Ribociclib 1374639-75-4 HR-erênî, HER2-neyînî Andvance ormetastatic Penceşêrên pêsîrê Novartis
PharmaceuticalsJun.27, 2028 -
Rivaroxaban
Navê API Delîl Specification DYA DMF EU DMF CEP Rivaroxaban Antikoagulant In-House TDP -
Rosuvastatin Calcium
Navê API Delîl Specification DYA DMF EU DMF CEP Rosuvastatin Calcium Hypercholesterolemia In-House / CEP 20705 √ CEP2015-240 -
Pitavastatin Calcium
Navê API Delîl Specification DYA DMF EU DMF CEP Pitavastatin Calcium Hypercholesterolemia In-House -
Pregabalin
Navê API Delîl Specification DYA DMF EU DMF CEP Pregabalin Epîlepsî/Neuralgia In-House / EP 22223 √ CEP2016-141 -
Acid Obeticholic
Navê API Delîl Specification DYA DMF EU DMF CEP Acid Obeticholic Kolangitis biliary In-House -
Niraparib 1038915-60-4
Navê API Delîl Innovator Dîroka Dawîbûna Patentê (DYA) Niraparib 1038915-60-4 Penceşêra hêk / Falopian, lûle / seretayî ya peritoneal Tesaro 8 Çile, 2028 -
Ledipasvir Actone / PVP
Navê API Delîl Specification DYA DMF EU DMF CEP Ledipasvir Actone / PVP HCV In-House √
